跳至主要内容
临床试验/CTRI/2025/09/094860
CTRI/2025/09/094860尚未招募2 期

Clinical evaluation of yava kshar with gokshuradi kashayam in mutrashmari (Renal calculi)

Gurukul Campus Uttarakhand Ayurved University Haridwar1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年9月30日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
1) Reduction in the size of calculi

研究概览

简要总结

Mutrashmari is one of the commonest disease of mutravaha Srotas, which is characterised by Pain in nabhi, basti, sevani, mehana, mutradharasangha (obstruction in urine),  sarudhiramutrata (Hematuria), mutravikiran (Double stream of urine). Rasatarangini has indicated  Yava kshar with Gokshuradi Kashayam as anupara in mutrashmari. This is an open-label, single-arm clinical trial conducted to evaluate the efficacy of Yava Kshara with Gokshuradi Kashaya in the management of Mutrashmari (urinary calculi). Yava Kshara is administered in capsule form at a dose of 1 capsule (500 mg) twice daily, along with 40 ml of Gokshuradi Kashaya as an anupana, taken before meals. The treatment duration is of 3 months, followed by a 1 month of follow-up. A total of 30 patients diagnosed with Mutrashmari is included in the study. The trial is conducted at the Gurukul Campus, Uttarakhand Ayurved University, Haridwar.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient having classical signs and symptoms of Mutrashmari will be included.
  • Patients of both sexes and above age of 18 years to 60 years age, irrespective of religion, socioeconomic status, occupation will be taken.
  • Patient having renal calculi with or without mild hydronephrosis will be selected.
  • Radiological evidence of (upto 8 mm) in kidney.

排除标准

  • Complications related to Kidneys/Ureter/Bladder like- Acute Renal Failure, Chronic Renal Failure, Polycystic Kidney diseases, Impaired Renal function.
  • Patients having systemic diseases like RHD, AIDS (Acquired immune deficiency syndrome).
  • Other chronic diseases like TB (Tuberculosis), Hepatitis etc.
  • will be excluded.
  • Pregnant women and lactating mothers will be excluded.
  • Patients having Moderate or severe Hydronephrosis, stag horn calculi will be excluded.

结局指标

主要结局

1) Reduction in the size of calculi

时间窗: 3 months

2) complete expulsion of calculi

时间窗: 3 months

次要结局

  • Sign and symptoms of mutrashmari will reduce with treatment(3 months)

研究者

发起方
Gurukul Campus Uttarakhand Ayurved University Haridwar
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Deeksha Joshi

Gurukul Campus Uttarakhand Ayurved University Haridwar

研究点 (1)

Loading locations...

相似试验